Neolys was born out of a common interest between industry and radiobiology researchers from Lyon, France to meet a particular need: predicting radiosensitivity reactions after radiotherapy for each patient, taking into account individual specificities.
Neolys thus developed a reliable technology based on predictive tests, allowing for patient-specific treatments. Our solutions both optimize radiotherapy treatments efficiency and toxicity prevention.
Neolys Diagnostics joined ALARA Group in late 2019.
Company Details
- Employees
- 10
- Founded
- -
- Address
- 7 Allée De L'europe, Strasbourg-Entzheim,67960,france
- co****@****ics.com
- Industry
- Medical Practices
- NAICS
-
Ambulatory Health Care ServicesOffices of Other Health PractitionersOutpatient Care CentersOther Ambulatory Health Care ServicesOffices of All Other Health PractitionersOutpatient Mental Health and Substance Abuse CentersAll Other Ambulatory Health Care ServicesOffices of PodiatristsBlood and Organ BanksAll Other Miscellaneous Ambulatory Health Care Services
- Website
- neolysdiagnostics.com
- Keywords
- Radiation Oncology, Radiosensitivity, Precision Medicine, Médecine personnalisée, Radiosensibilité, Radiothérapie.
- HQ
- Strasbourg-Entzheim
Neolys Diagnostics Questions
Neolys Diagnostics's website is neolysdiagnostics.com
Neolys Diagnostics's LinkedIn profile is https://fr.linkedin.com/company/neolys-diagnostics
Neolys Diagnostics has
10 employees.
View email and phone details for 10
employees at Neolys Diagnostics.
Neolys Diagnostics's industry is
Medical Practices
Neolys Diagnostics's top competitors are
Innov'ncare,
Eurofins Calixar,
Recobia Therapeutics,
Alara Group,
Letsee Imaging,
Gmt Science,
Seekyo Therapeutics,
Starkage Therapeutics,
Fibermetrix,
Alara Expertise.
Neolys Diagnostics's support email address is contact@neolysdiagnostics.com
Neolys Diagnostics's categories are Medical Practices
Neolys Diagnostics's founding year is 2014
